Veraxa Biotech Holding AG (VRXA) Goodwill (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Goodwill came in at $28.6 million in Q4 2025, up 9.61% year-on-year from $26.1 million in Q4 2024, and up 9.61% on a QoQ basis from $26.1 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Goodwill (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Goodwill data on file, last reported at $28.6 million in Q4 2025.
- On a quarterly basis, Goodwill rose 9.61% year-over-year to $28.6 million in Q4 2025; TTM through Dec 2025 was $28.6 million, a 9.61% increase from a year earlier, with the FY2025 full-year figure at $28.6 million, up 9.61% from the prior year.
- Goodwill for Q4 2025 stood at $28.6 million, up from $26.1 million in the prior quarter.
- Over the last five years, Goodwill for VRXA reached as high as $28.6 million in Q4 2025 and fell as low as $26.1 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.59 Mn |
| Dec 31, 2024 | 26.08 Mn |